Measures and Outcomes: Insulin infusion strategy was considered to be variable if the infusion rate changed within the first 8 hours of therapy or was considered fixed if the rate remained unchanged for the same period. The primary outcome was time to resolution of DKA. Secondary outcomes were...
Presbyopia of degrees is not fixed does not variable of, flexor light does not are, and with eye method, and personal of physical fitness, and location (because temperature on lens of effect, life in Equatorial near of people more easy presbyopia), and taking insulin, and anti-anxiety drug...
Garg S,Selam J,Bhargava A,et al.Similar Hb A1c reduction and hypoglycaemia with variable-vs.fixed-time dosing of basal insulin peglispro in type 1 diabetes:IMAGINE 7 study[J].Diabetes Obes Metab,2016,18 Suppl 2(S2):43.Garg S, Selam JL, Bhargava A, et al. Similar HbA1c reduction and...
variable‐time dosingAimsTo compare 24-hour fixed-time basal insulin peglispro (BIL) dosing with 8- to 40-hour variable-time BIL dosing for glycaemic control and safety in patients with type 1 diabetes. Primary outcome was non-inferiority of BIL variable-time dosing compared with fixed-time ...
distribution was Gaussian; while for the microaneurysm the distribution was Poisson. The Poisson function was chosen due to the fact that microaneurysms were considered as a counting variable. Poisson function was applicable because there was no overdispersion. To analyze the overall treatment effect, ...
By forming a gel layer, the HPMC protects the disintegration of the matrix and delays the drug release rate [44]. The effect of CMAs on the intrinsic dissolution rate (y8) was described as a coded equation with a linear mathematical model. Based on the ANOVA results, the significant CMAs ...